Interstitial lung disease (ILD) during gefitinib treatment in Japanese patients with non-small cell lung cancer (NSCLC): Okayama Lung Cancer Study Group

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7063-7063 ◽  
Author(s):  
K. Hotta ◽  
S. Harita ◽  
A. Bessho ◽  
T. Yonei ◽  
K. Gemba ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document